APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pertuzumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pertuzumab Industry Growth and Trends Forecast to 2032

Report ID 174024010126 December 202599 pages

Choose your research edition.

Industry ResearchPertuzumab Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pertuzumab Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Pertuzumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pertuzumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pertuzumab Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pertuzumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pertuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pertuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pertuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pertuzumab include Abnova Corporation, Biocon Limited, Bio-Techne, Celltrion, InvivoGen, Pfizer and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pertuzumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pertuzumab market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pertuzumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pertuzumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pertuzumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pertuzumab Market by Company

Abnova Corporation

Biocon Limited

Bio-Techne

Celltrion

InvivoGen

Pfizer

Novartis AG

Pertuzumab Segment by Type

Human Source

Animal Source

Pertuzumab Segment by Application

Hospital

Medical Center

Pertuzumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertuzumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pertuzumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertuzumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pertuzumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Source Table 2. Major Company of Animal Source Table 3. Global Pertuzumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pertuzumab Sales by Type (2021-2026) & (Tons) Table 5. Global Pertuzumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pertuzumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Pertuzumab Price by Type (2021-2026) & (US$/Ton) Table 9. Global Pertuzumab Sales by Type (2027-2032) & (Tons) Table 10. Global Pertuzumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pertuzumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pertuzumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Pertuzumab Price by Type (2027-2032) & (US$/Ton) Table 14. North America Pertuzumab Sales by Type (2021-2026) & (Tons) Table 15. North America Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pertuzumab Sales by Type (2021-2026) & (Tons) Table 17. Europe Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pertuzumab Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pertuzumab Sales by Type (2021-2026) & (Tons) Table 21. Latin America Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pertuzumab Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Pertuzumab Sales by Type (2021-2026) & (US$ Million) Table 24. Pertuzumab Industry Trends Table 25. Pertuzumab Industry Drivers Table 26. Pertuzumab Industry Opportunities and Challenges Table 27. Pertuzumab Industry Restraints Table 28. Global Pertuzumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pertuzumab Revenue Market Share by Company (2021-2026) Table 30. Global Pertuzumab Sales by Company (2021-2026) & (Tons) Table 31. Global Pertuzumab Sales Share by Company (2021-2026) Table 32. Global Pertuzumab Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Pertuzumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pertuzumab Major Company Production Sites and Headquarters Table 35. Global Pertuzumab Company, Product Type & Application Table 36. Global Pertuzumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pertuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pertuzumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pertuzumab Sales by Region (2021-2026) & (Tons) Table 41. Global Pertuzumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pertuzumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pertuzumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Pertuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Pertuzumab Sales by Region (2027-2032) & (Tons) Table 46. Global Pertuzumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pertuzumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pertuzumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Pertuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Pertuzumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pertuzumab Sales by Application (2021-2026) & (Tons) Table 52. Global Pertuzumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pertuzumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Pertuzumab Price by Application (2021-2026) & (US$/Ton) Table 56. Global Pertuzumab Sales by Application (2027-2032) & (Tons) Table 57. Global Pertuzumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pertuzumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pertuzumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Pertuzumab Price by Application (2027-2032) & (US$/Ton) Table 61. North America Pertuzumab Sales by Application (2021-2026) & (Tons) Table 62. North America Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pertuzumab Sales by Application (2021-2026) & (Tons) Table 64. Europe Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pertuzumab Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pertuzumab Sales by Application (2021-2026) & (Tons) Table 68. Latin America Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pertuzumab Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Pertuzumab Sales by Application (2021-2026) & (US$ Million) Table 71. Abnova Corporation Company Information Table 72. Abnova Corporation Business Overview Table 73. Abnova Corporation Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Abnova Corporation Pertuzumab Product Portfolio Table 75. Abnova Corporation Recent Development Table 76. Biocon Limited Company Information Table 77. Biocon Limited Business Overview Table 78. Biocon Limited Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Biocon Limited Pertuzumab Product Portfolio Table 80. Biocon Limited Recent Development Table 81. Bio-Techne Company Information Table 82. Bio-Techne Business Overview Table 83. Bio-Techne Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Bio-Techne Pertuzumab Product Portfolio Table 85. Bio-Techne Recent Development Table 86. Celltrion Company Information Table 87. Celltrion Business Overview Table 88. Celltrion Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Celltrion Pertuzumab Product Portfolio Table 90. Celltrion Recent Development Table 91. InvivoGen Company Information Table 92. InvivoGen Business Overview Table 93. InvivoGen Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. InvivoGen Pertuzumab Product Portfolio Table 95. InvivoGen Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Pfizer Pertuzumab Product Portfolio Table 100. Pfizer Recent Development Table 101. Novartis AG Company Information Table 102. Novartis AG Business Overview Table 103. Novartis AG Pertuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Novartis AG Pertuzumab Product Portfolio Table 105. Novartis AG Recent Development Table 106. North America Pertuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 107. North America Pertuzumab Sales by Country (2021-2026) & (Tons) Table 108. North America Pertuzumab Sales Market Share by Country (2021-2026) Table 109. North America Pertuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 110. North America Pertuzumab Sales Market Share Forecast by Country (2027-2032) Table 111. North America Pertuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Pertuzumab Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Pertuzumab Market Share by Country (2021-2026) Table 114. North America Pertuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Pertuzumab Market Share Forecast by Country (2027-2032) Table 116. Europe Pertuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 117. Europe Pertuzumab Sales by Country (2021-2026) & (Tons) Table 118. Europe Pertuzumab Sales Market Share by Country (2021-2026) Table 119. Europe Pertuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 120. Europe Pertuzumab Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Pertuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Pertuzumab Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Pertuzumab Market Share by Country (2021-2026) Table 124. Europe Pertuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Pertuzumab Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Pertuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Pertuzumab Sales by Country (2021-2026) & (Tons) Table 128. Asia-Pacific Pertuzumab Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Pertuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 130. Asia-Pacific Pertuzumab Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Pertuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Pertuzumab Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Pertuzumab Market Share by Country (2021-2026) Table 134. Asia-Pacific Pertuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Pertuzumab Market Share Forecast by Country (2027-2032) Table 136. Latin America Pertuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 137. Latin America Pertuzumab Sales by Country (2021-2026) & (Tons) Table 138. Latin America Pertuzumab Sales Market Share by Country (2021-2026) Table 139. Latin America Pertuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 140. Latin America Pertuzumab Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Pertuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Pertuzumab Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Pertuzumab Market Share by Country (2021-2026) Table 144. Latin America Pertuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Pertuzumab Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Pertuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Pertuzumab Sales by Country (2021-2026) & (Tons) Table 148. Middle East and Africa Pertuzumab Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Pertuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 150. Middle East and Africa Pertuzumab Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Pertuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Pertuzumab Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Pertuzumab Market Share by Country (2021-2026) Table 154. Middle East and Africa Pertuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Pertuzumab Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Pertuzumab Distributors List Table 159. Pertuzumab Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Pertuzumab Image Figure 2. Global Pertuzumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pertuzumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Pertuzumab Sales (2021-2032) & (Tons) Figure 5. Human Source Image Figure 6. Global Human Source Sales YoY Growth (2021-2032) & (Tons) Figure 7. Animal Source Image Figure 8. Global Animal Source Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Pertuzumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pertuzumab Market Share by Type 2025 VS 2032 Figure 11. North America Pertuzumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Pertuzumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Pertuzumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pertuzumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pertuzumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pertuzumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pertuzumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pertuzumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pertuzumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pertuzumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pertuzumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 25. Medical Center Image Figure 26. Global Medical Center Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Pertuzumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Pertuzumab Market Share by Application 2025 VS 2032 Figure 29. North America Pertuzumab Sales Market Share in Volume by Application in 2025 Figure 30. North America Pertuzumab Sales Market Share in Value by Application in 2025 Figure 31. Europe Pertuzumab Sales Market Share in Volume by Application in 2025 Figure 32. Europe Pertuzumab Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Pertuzumab Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Pertuzumab Sales Market Share in Value by Application in 2025 Figure 35. Latin America Pertuzumab Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Pertuzumab Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Pertuzumab Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Pertuzumab Sales Market Share in Value by Application in 2025 Figure 39. North America Pertuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Pertuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Pertuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Pertuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Pertuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Pertuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pertuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pertuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Pertuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Pertuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pertuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Pertuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Pertuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Pertuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pertuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Pertuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Pertuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Pertuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pertuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Pertuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Pertuzumab Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Pertuzumab Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Human Source
  • Animal Source
Applications
  • Hospital
  • Medical Center
Companies covered
  • Abnova Corporation
  • Biocon Limited
  • Bio-Techne
  • Celltrion
  • InvivoGen
  • Pfizer
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pertuzumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pertuzumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pertuzumab Market by Type
  6. 1.3.1 Human Source
  7. 1.3.2 Animal Source
  8. 1.4 Global Pertuzumab Market Size by Type
  9. 1.4.1 Global Pertuzumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pertuzumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pertuzumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pertuzumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pertuzumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pertuzumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pertuzumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pertuzumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pertuzumab Industry Trends
  2. 2.2 Pertuzumab Industry Drivers
  3. 2.3 Pertuzumab Industry Opportunities and Challenges
  4. 2.4 Pertuzumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pertuzumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Pertuzumab Sales (2021-2026)
  3. 3.3 Global Top Players by Pertuzumab Price (2021-2026)
  4. 3.4 Global Pertuzumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pertuzumab Major Company Production Sites & Headquarters
  6. 3.6 Global Pertuzumab Company, Product Type & Application
  7. 3.7 Global Pertuzumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pertuzumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pertuzumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pertuzumab Tier 1, Tier 2, and Tier 3
4 Pertuzumab Regional Status and Outlook
  1. 4.1 Global Pertuzumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pertuzumab Historic Market Size by Region
  3. 4.2.1 Global Pertuzumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pertuzumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pertuzumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pertuzumab Forecasted Market Size by Region
  7. 4.3.1 Global Pertuzumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pertuzumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pertuzumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pertuzumab by Application
  1. 5.1 Pertuzumab Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Center
  4. 5.2 Global Pertuzumab Market Size by Application
  5. 5.2.1 Global Pertuzumab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pertuzumab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pertuzumab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pertuzumab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pertuzumab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pertuzumab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pertuzumab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pertuzumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abnova Corporation
  2. 6.1.1 Abnova Corporation Company Information
  3. 6.1.2 Abnova Corporation Business Overview
  4. 6.1.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abnova Corporation Pertuzumab Product Portfolio
  6. 6.1.5 Abnova Corporation Recent Developments
  7. 6.2 Biocon Limited
  8. 6.2.1 Biocon Limited Company Information
  9. 6.2.2 Biocon Limited Business Overview
  10. 6.2.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biocon Limited Pertuzumab Product Portfolio
  12. 6.2.5 Biocon Limited Recent Developments
  13. 6.3 Bio-Techne
  14. 6.3.1 Bio-Techne Company Information
  15. 6.3.2 Bio-Techne Business Overview
  16. 6.3.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Techne Pertuzumab Product Portfolio
  18. 6.3.5 Bio-Techne Recent Developments
  19. 6.4 Celltrion
  20. 6.4.1 Celltrion Company Information
  21. 6.4.2 Celltrion Business Overview
  22. 6.4.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Celltrion Pertuzumab Product Portfolio
  24. 6.4.5 Celltrion Recent Developments
  25. 6.5 InvivoGen
  26. 6.5.1 InvivoGen Company Information
  27. 6.5.2 InvivoGen Business Overview
  28. 6.5.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 InvivoGen Pertuzumab Product Portfolio
  30. 6.5.5 InvivoGen Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Pertuzumab Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Novartis AG
  38. 6.7.1 Novartis AG Company Information
  39. 6.7.2 Novartis AG Business Overview
  40. 6.7.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis AG Pertuzumab Product Portfolio
  42. 6.7.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America Pertuzumab Sales by Country
  2. 7.1.1 North America Pertuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pertuzumab Sales by Country (2021-2026)
  4. 7.1.3 North America Pertuzumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pertuzumab Market Size by Country
  6. 7.2.1 North America Pertuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pertuzumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Pertuzumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pertuzumab Sales by Country
  2. 8.1.1 Europe Pertuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pertuzumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Pertuzumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pertuzumab Market Size by Country
  6. 8.2.1 Europe Pertuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pertuzumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pertuzumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pertuzumab Sales by Country
  2. 9.1.1 Asia-Pacific Pertuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pertuzumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pertuzumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pertuzumab Market Size by Country
  6. 9.2.1 Asia-Pacific Pertuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pertuzumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pertuzumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pertuzumab Sales by Country
  2. 10.1.1 South America Pertuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pertuzumab Sales by Country (2021-2026)
  4. 10.1.3 South America Pertuzumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pertuzumab Market Size by Country
  6. 10.2.1 South America Pertuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pertuzumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Pertuzumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pertuzumab Sales by Country
  2. 11.1.1 Middle East and Africa Pertuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pertuzumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pertuzumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pertuzumab Market Size by Country
  6. 11.2.1 Middle East and Africa Pertuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pertuzumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pertuzumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pertuzumab Value Chain Analysis
  2. 12.1.1 Pertuzumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pertuzumab Production Mode & Process
  7. 12.2 Pertuzumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pertuzumab Distributors
  10. 12.2.3 Pertuzumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst